New York, Jan 8, 2026, 15:35 ET — Regular session.
- Procter & Gamble shares rose about 2.4% in afternoon trade on Thursday
- Texas deal targets Kid’s Crest packaging and marketing for children’s toothpaste
- Next scheduled catalyst is P&G’s Jan. 22 earnings report and conference call
Procter & Gamble stock rose 2.4% to $141.38 on Thursday, after swinging between $137.81 and $141.78, as investors weighed a Texas agreement over Crest children’s toothpaste labeling. Texas Attorney General Ken Paxton said Kid’s Crest packaging and marketing must “clearly depict the appropriate amount” of toothpaste for children, and P&G said it was “fully committed” to safe products as it “voluntarily” changes its artwork. A statement from Paxton’s office noted the roll-out began Jan. 1 and requires five years of compliance; Colgate-Palmolive reached a similar agreement in September, and a private lawsuit over Kid’s Crest labels survived a bid to dismiss it in federal court. Reuters
Why this matters now is less about one toothpaste box and more about friction. Consumer staples live on trust and repeat buys; disputes over children’s products can force fast changes that ripple through marketing, packaging and legal budgets.
For investors, that timing is awkward. Earnings season is close, and even small regulatory or legal issues tend to get more attention when companies are about to talk guidance and costs.
In the wider market, U.S. stocks were mixed on Thursday as technology shares slipped and defense names climbed after President Donald Trump called for a bigger military budget, leaving the major indexes little changed on the day. Traders also parsed weekly jobless claims and are looking to Friday’s nonfarm payrolls report — the monthly snapshot of U.S. hiring — for fresh signals on rates.
P&G came into Thursday on a weak run. The stock fell 1.34% to $138.04 on Wednesday for a seventh straight daily decline, and it was trading about 23% below its 52-week high set in March, MarketWatch data showed.
The next company readout is Jan. 22, when P&G is due to report fiscal second-quarter results before the market opens and host a conference call at 8:30 a.m. ET. Traders will be watching for any sign the company is absorbing higher legal, compliance or marketing costs, alongside the usual focus on pricing and unit volumes.
But the toothpaste agreement does not close the book on fluoride scrutiny, and it won’t settle the private litigation on its own. Any widening of state investigations or adverse court rulings could keep the story alive and complicate brand messaging in oral care.
Investors get the next hard set of numbers and commentary on Jan. 22.
